Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction

Journal Title: Journal of Medical and Allied Sciences - Year 2011, Vol 1, Issue 1

Abstract

This study addresses the issues in translating the laboratory derived data obtained during discovery phase of research to a clinical setting using a breast cancer model. Laboratory-based risk assessment indicated that a family history of breast cancer, reduced folate carrier 1 (RFC1) G80A, thymidylate synthase (TYMS) 5’-UTR 28bp tandem repeat, methylene tetrahydrofolate reductase (MTHFR) C677T and catecholamine-O-methyl transferase (COMT) genetic polymorphisms in one-carbon metabolic pathway increase the risk for breast cancer. Glutamate carboxypeptidase II (GCPII) C1561T and cytosolic serine hydroxymethyl transferase (cSHMT) C1420T polymorphisms were found to decrease breast cancer risk. In order to test the clinical validity of this information in the risk prediction of breast cancer, data was stratified based on number of protective alleles into four categories and in each category sensitivity and 1-specificity values were obtained based on the distribution of number of risk alleles in cases and controls. Receiver operating characteristic (ROC) curves were plotted and the area under ROC curve (C) was used as a measure of discriminatory ability between cases and controls. In subjects without any protective allele, aberrations in one-carbon metabolism showed perfect prediction (C=0.93) while the predictability was lost in subjects with one protective allele (C=0.60). However, predictability increased steadily with increasing number of protective alleles (C=0.63 for 2 protective alleles and C=0.71 for 3 protective alleles). The cut-off point for discrimination was >4 alleles in all predictable combinations. Models of this kind can serve as valuable tools in translational research, especially in identifying high-risk individuals and reducing the disease risk either by life style modification or by medical intervention.

Authors and Affiliations

Shaik Mohammad Naushad| Department of Clinical Pharmacology & Therapeutics, Shree Divyya| Department of Clinical Pharmacology & Therapeutics, Addepalli Pavani| Department of Clinical Pharmacology & Therapeutics, Yedluri Rupasree| Department of Clinical Pharmacology & Therapeutics, Raghunadha Rao Digumarti| Department of Medical Oncology, Suryanarayana Raju Gottumukkala| Surgical Oncology, Nizam’s Institute of Medical Sciences, Panjagutta, Hyderabad 500 082, Andhra Pradesh, India, Vijay Kumar Kutala| Department of Clinical Pharmacology & Therapeutics

Keywords

Related Articles

Heterotaxy syndrome with associated agenesis of dorsal pancreas and polysplenia: A case report

Heterotaxy syndrome is a rare embryological disorder comprising of polysplenia, partial agenesis of dorsal pancreas, malrotation of gut, cardiac and vascular anomalies resulting from failure of development of the usual...

Neurodegenerative changes in different regions of brain, spinal cord and sciatic nerve of rats treated with sodium fluoride

Fluoride is known to cross the blood-brain barrier and alter the structure and function of neural tissue. There are few authoritative reports on neurodegenerative changes in hippocampus, neocortex, cerebellum, spinal...

Structured exercise interventions for type 2 diabetes mellitus: Strength of current evidence

Exercise, along with medical nutrition therapy and pharmacological interventions, is an important component in the clinical management of type 2 diabetes mellitus. Current clinical guidelines on Type 2 diabetes provid...

Simultaneous detection of Hepatitis B virus and Hepatitis C virus in human plasma using Taq-man chemistry

Designing a rapid, reliable and sensitive assay, for detection of hepatitis B virus and Hepatitis C virus variants by real-time PCR, is challenging at best. A recent approach for quantifying the viral load using the s...

A rare cause of internal herniation - Intermesocolic fossa of Brosike

Internal Hernias are defined as “The protrusion of viscera through a normal or abnormal opening within the boundaries of the peritoneal cavity” which account for 0.5 – 5.8% of small bowel obstructions while Autops...

Download PDF file
  • EP ID EP12640
  • DOI -
  • Views 517
  • Downloads 49

How To Cite

Shaik Mohammad Naushad, Shree Divyya, Addepalli Pavani, Yedluri Rupasree, Raghunadha Rao Digumarti, Suryanarayana Raju Gottumukkala, Vijay Kumar Kutala (2011). Clinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction. Journal of Medical and Allied Sciences, 1(1), 7-13. https://europub.co.uk/articles/-A-12640